Comparison of the prognostic value of SPECT after nitrate administration and metabolic imaging by PET in patients with ischaemic left ventricular dysfunction
Comparison of the prognostic value of SPECT after nitrate administration and metabolic imaging by PET in patients with ischaemic left ventricular dysfunction(141 visite) Sorrentino AR, Acampa W, Petretta M, Mainolfi C, Salvatore M, Cuocolo A
Parole chiave: Lv Dysfunction, Pet Imaging, Prognosis, Spect Imaging, Fluorodeoxyglucose F 18, Isosorbide Dinitrate, Tetrofosmin Tc 99m, Adult, Controlled Study, Diabetes Mellitus, Drug Uptake, Female, Follow Up, Heart Death, Heart Ejection Fraction, Heart Infarction, Heart Left Ventricle Failure, Heart Muscle, Human, Major Clinical Study, Medical Record, Metabolism, Positron Emission Tomography, Revascularization, Review, Single Photon Emission Computer Tomography, Survival, Unstable Angina Pectoris, Image Enhancement, Middle Aged, Myocardial Ischemia, Positron-Emission Tomography, Reproducibility Of Results, Sensitivity And Specificity, Emission-Computed, Single-Photon, Vasodilator Agents, Ventricular Dysfunction,
Affiliazioni:
*** IBB - CNR *** Department of Biomorphological and Functional Sciences, Institute of Biostructures and Bioimages of the National Council of Research, University Federico II, Naples, Italy Department of Internal Medicine, Cardiovascular and Immunological Sciences, University Federico II, Naples, Italy
Riferimenti:
Patterson, R.E., Pilcher, W.C., Assessing myocardial viability to help select patients for revascularization to improve left ventricular dysfunction due to coronary artery disease (1995) Semin Thorac Cardiovasc Surg, 7, pp. 214-22
Allman, K.C., Shaw, L.J., Hachamovitch, R., Udelson, J.E., Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: A meta-analysis (2002) J Am Coll Cardiol, 39, pp. 1151-1158
Travin, M.I., Bergmann, S.R., Assessment of myocardial viability (2005) Semin Nucl Med, 35, pp. 2-16
He, Z.X., Yang, M.F., Liu, X.J., Shi, R.F., Gao, R.L., Hu, S.S., Association of myocardial viability on nitrate-augmented technetium-99m hexakis-2- methoxylisobutyl isonitrile myocardial tomography and intermediate-term outcome in patients with prior myocardial infarction and left ventricular dysfunction (2003) Am J Cardiol, 92, pp. 696-699
He, W., Acampa, W., Mainolfi, C., Menna, F., Sorrentino, A.R., Petretta, M., Tc-99m tetrofosmin tomography after nitrate administration in patients with ischemic left ventricular dysfunction: Relation to metabolic imaging by PET (2003) J Nucl Cardiol, 10, pp. 599-606
Cuocolo, A., Petretta, M., Nicolai, E., Pace, L., Bonaduce, D., Salvatore, M., Successful coronary revascularization improves prognosis in patients with previous myocardial infarction and evidence of viable myocardium at thallium-201 imaging (1998) Eur J Nucl Med, 25, pp. 60-68
Acampa, W., Cuocolo, A., Petretta, M., Bruno, A., Castellani, M., Finzi, A., Tetrofosmin imaging in the detection of myocardial viability in patients with previous myocardial infarction: Comparison with sestamibi and Tl-201 scintigraphy (2002) J Nucl Cardiol, 9, pp. 33-40
Bonow, R.O., Dilsizian, V., Cuocolo, A., Bacharach, S., Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose (1991) Circulation, 83, pp. 26-37
Cohen, J., A coefficient of agreement for nominal scales (1960) Educ Psychol Meas, 20, pp. 37-46
Fleiss JL. Statistical methods for rates and proportions, 2nd ed. New York, NY: Wesley and Sons
1981, p. 217-225Altehoefer, C., Kaiser, H.J., Dorr, R., Feinendegen, C., Beilin, I., Uebis, R., Fluorine-18 deoxyglucose PET for assessment of viable myocardium in perfusion defects in 99mTc-MIBI SPET: A comparative study in patients with coronary artery disease (1992) Eur J Nucl Med, 19, pp. 334-342
Dilsizian, V., Arrighi, J.A., Diodati, J.G., Quyyumi, A.A., Alavi, K., Bacharach, S.L., Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [ 18F]fluorodeoxyglucose (1994) Circulation, 89, pp. 578-587
Sciagrà, R., Pellegri, M., Pupi, A., Bolognese, L., Bisi, G., Carnovale, V., Prognostic implications of Tc-99m sestamibi viability imaging and subsequent therapeutic strategy in patients with chronic coronary artery disease and left ventricular dysfunction (2000) J Am Coll Cardiol, 36, pp. 739-745
Desideri, A., Cortigiani, L., Christen, A.I., Coscarelli, S., Gregori, D., Zanco, P., The extent of perfusion-F18-fluorodeoxyglucose positron emission tomography mismatch determines mortality in medically treated patients with chronic ischemic left ventricular dysfunction (2005) J Am Coll Cardiol, 46, pp. 1264-1269
Siebelink, H.M., Blanksma, P.K., Crijns, H.J., Bax, J.J., van Boven, A.J., Kingma, T., No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: A prospective, randomized comparison of patients with suspicion of jeopardized myocardium (2001) J Am Coll Cardiol, 37, pp. 81-88
Kaul, S., Response of dysfunctional myocardium to dobutamine. The eyes see what the mind knows (1996) J Am Coll Cardiol, 27, pp. 1608-1611
Patterson, R. E., Pilcher, W. C., Assessing myocardial viability to help select patients for revascularization to improve left ventricular dysfunction due to coronary artery disease (1995) Semin Thorac Cardiovasc Surg, 7, pp. 214-22
Allman, K. C., Shaw, L. J., Hachamovitch, R., Udelson, J. E., Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: A meta-analysis (2002) J Am Coll Cardiol, 39, pp. 1151-1158
Travin, M. I., Bergmann, S. R., Assessment of myocardial viability (2005) Semin Nucl Med, 35, pp. 2-16
He, Z. X., Yang, M. F., Liu, X. J., Shi, R. F., Gao, R. L., Hu, S. S., Association of myocardial viability on nitrate-augmented technetium-99m hexakis-2- methoxylisobutyl isonitrile myocardial tomography and intermediate-term outcome in patients with prior myocardial infarction and left ventricular dysfunction (2003) Am J Cardiol, 92, pp. 696-699
Bonow, R. O., Dilsizian, V., Cuocolo, A., Bacharach, S., Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose (1991) Circulation, 83, pp. 26-37
Sciagr, R., Pellegri, M., Pupi, A., Bolognese, L., Bisi, G., Carnovale, V., Prognostic implications of Tc-99m sestamibi viability imaging and subsequent therapeutic strategy in patients with chronic coronary artery disease and left ventricular dysfunction (2000) J Am Coll Cardiol, 36, pp. 739-745
Siebelink, H. M., Blanksma, P. K., Crijns, H. J., Bax, J. J., van Boven, A. J., Kingma, T., No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: A prospective, randomized comparison of patients with suspicion of jeopardized myocardium (2001) J Am Coll Cardiol, 37, pp. 81-88
Antonini A, Vitale C, Barone P, Cilia R, Righini A, Bonuccelli U, Abbruzzese G, Ramat S, Petrone A, Quatrale R, Marconi R, Ceravolo R, Stefani A, Lopiano L, Zappia M, Capus L, Morgante L, Tamma F, Tinazzi M, Colosimo C, Guerra UP, Valzania F, Fagioli G, Distefano A, Bagnato A, Feggi L, Anna S, Maria Teresa Rosaria De Cr, Nobili F, Mazzuca N, Baldari S, Eleopra R, Bestetti A, Benti R, Varrone A, Volterrani D, Massa R, Stocchi F, Schillaci O, Dore F, Zibetti M, Castellano G, Battista SG, Giorgetti G * The relationship between cerebral vascular disease and parkinsonism: The VADO study(200 visite) Parkinsonism Relat D (ISSN: 1353-8020, 1873-5126, 1873-5126electronic), 2012; 18(6): 775-780. Impact Factor:3.274 DettagliEsporta in BibTeXEsporta in EndNote
209 Records (193 escludendo Abstract e Conferenze). Impact factor totale: 663.474 (599.025 escludendo Abstract e Conferenze). Impact factor a 5 anni totale: 707.635 (638.531 escludendo Abstract e Conferenze).
ibb.cnr.it
